News – Page 519 – Endpoints News

Alnylam boasts PhII win in kidney disease cornerstone of Regeneron R&D blockbuster deal

3 years ago

Senti Bio completes its SPAC merger, though not before seeing investors 'playing a financial game'

3 years ago

During tepid public market, Biospring closes quarter billion dollar manufacturing and tech-focused fund

3 years ago

Unlike 1-day VRBPAC-to-EUA timeline of peers, Novavax’s Covid-19 jab awaits FDA review of recent manufacturing data

3 years ago

Exclusive: After Amgen exit, father-son duo gets Lightspeed backing to fund remaining Teneobio 'babies'

3 years ago

House passes bipartisan FDA user fee legislation as it aligns with Senate on accelerated approval reforms

3 years ago

Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D

3 years ago

Armed with library of molecular glues, Degron launches out of a Shanghai lab

3 years ago

With deep ties to Baylor and fresh support from Polaris, Singapore's Tessa raises $126M for pivotal CAR study

3 years ago

Big names, big backers: David Baker joins OrbiMed, F-Prime, Khosla and others as protein-ligand biotech launches

3 years ago

Amidst a struggling IPO market, Forbion drums up half a billion in private cash for second late-stage fund

3 years ago

New GSK debuts with renewed purpose, strategy and brand identity as it says goodbye to consumer business

3 years ago

Harvard, Kesselheim paper highlights almost 90x increase in launch prices for new drugs since 2008

3 years ago

EMA to keep closer tabs on supplies of all approved Covid-19 vaccines and therapeutics

3 years ago

Resilience nets another deal, this time with billionaire’s cancer research center

3 years ago

IPG Health launches 90North agency with biopharma future look

3 years ago

WTO approaches a deal early next week for a Covid-19 vaccine IP waiver

3 years ago

Obesity drug race heats up as Innovent uncorks new GLP1 data

3 years ago

Equal Employment Opportunity Commission brings Novo Nordisk to court over age discrimination case

3 years ago

CSL's Seqirus caps off $156M expansion of flu manufacturing facility in Raleigh suburb

3 years ago

Following tie-up with Sanofi, transatlantic AI firm secures latest Big Pharma deal in nine-figure Bristol Myers pact

3 years ago

RA Capital backs a Philly biotech's $118M crossover as it aims to break into the hypertension space

3 years ago

Moderna says Omicron-specific booster better than current shot, aims for late summer approval

3 years ago

For Rigel, a surprising placebo response spurs a PhIII fail, stock beating. But it's been here before

3 years ago

First page Previous page 516 517 518519520 521 522 Next page Last page